A novel mitochondrial-associated risk score reveals a potential link between pancreatic ductal adenocarcinoma and chemotherapy resistance as well as poor response to immunotherapy.
Saved in:
| Title: | A novel mitochondrial-associated risk score reveals a potential link between pancreatic ductal adenocarcinoma and chemotherapy resistance as well as poor response to immunotherapy. |
|---|---|
| Authors: | Zhang Q; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116000, China., Tan G; Department of General Surgery, The First Affiliated Hospital of Dalian Medical University, Dalian, 116000, China. 15315043982@163.com. |
| Source: | Discover oncology [Discov Oncol] 2026 Apr 22; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 22. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2730-6011 |
|---|---|
| DOI: | 10.1007/s12672-026-05006-z |
